Thermo Fisher Scientific Deferred Tax Assets and Other Non-Current Assets increased by 1.7% to $5.97B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 32.3%, from $4.52B to $5.97B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 116.3% CAGR.
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
deferred_tax_assets_other_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.58B | $2.99B | $251.00M | $4.42B | $4.31B | $4.31B | $435.00M | $3.98B | $4.11B | $4.12B | $329.00M | $4.24B | $4.38B | $4.18B | $4.49B | $4.52B | $4.62B | $5.02B | $5.87B | $5.97B |
| QoQ Change | — | +15.8% | -91.6% | >999% | -2.7% | +0.0% | -89.9% | +815.6% | +3.1% | +0.4% | -92.0% | >999% | +3.2% | -4.5% | +7.5% | +0.5% | +2.2% | +8.8% | +17.0% | +1.7% |
| YoY Change | — | — | — | — | +66.6% | +44.0% | +73.3% | -10.0% | -4.6% | -4.3% | -24.4% | +6.5% | +6.5% | +1.4% | >999% | +6.5% | +5.4% | +20.1% | +30.7% | +32.3% |